Cabaletta Bio (CABA) Capital Expenditures Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | -372.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -372.34% |
| Sep 30, 2025 | -32.81% |
| Jun 30, 2025 | 114.98% |
| Dec 31, 2024 | 88.00% |
| Sep 30, 2024 | 2,146.15% |
| Jun 30, 2024 | -603.51% |
| Mar 31, 2024 | 74.21% |
| Dec 31, 2023 | 109.36% |
| Sep 30, 2023 | -96.22% |
| Jun 30, 2023 | -78.81% |
| Mar 31, 2023 | 158.50% |
| Dec 31, 2022 | -296.06% |
| Sep 30, 2022 | 520.78% |
| Jun 30, 2022 | 146.79% |
| Mar 31, 2022 | -60.90% |
| Dec 31, 2021 | 380.18% |
| Sep 30, 2021 | -352.47% |
| Jun 30, 2021 | 445.00% |
| Mar 31, 2021 | 66.37% |
| Dec 31, 2020 | 336.54% |
| Sep 30, 2020 | 178.64% |
| Jun 30, 2020 | -90.00% |
| Mar 31, 2020 | 25.56% |